Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

A patent perspective on US stem cell research.

Chan AW, Wong AY, Lee HM.

Nat Biotechnol. 2014 Jul;32(7):633-7. doi: 10.1038/nbt.2945. No abstract available.

PMID:
25004228
[PubMed - in process]
2.

The stem cell patent landscape as relevant to cancer vaccines.

Wang SJ.

Hum Vaccin. 2011 Oct;7(10):1100-8. doi: 10.4161/hv.7.10.17022. Epub 2011 Oct 1.

PMID:
21957493
[PubMed - indexed for MEDLINE]
Free Article
3.

Trends in the human embryonic stem cell patent field.

Karlsson U, Hyllner J, Runeberg K.

Recent Pat Nanotechnol. 2007;1(3):233-7. Review.

PMID:
19076035
[PubMed - indexed for MEDLINE]
4.

The attack of the clones: patent law and stem cell research.

Rimmer M.

J Law Med. 2003 May;10(4):488-505. Review.

PMID:
12852321
[PubMed - indexed for MEDLINE]
5.

US patent reform: a European perspective.

Atkinson JD, Jones RS.

Pharm Pat Anal. 2012 Jul;1(3):249-53. doi: 10.4155/ppa.12.32.

PMID:
24236837
[PubMed - indexed for MEDLINE]
6.

INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.

[No authors listed]

BioDrugs. 2003;17(3):216-22. Review.

PMID:
12749760
[PubMed - indexed for MEDLINE]
7.

Intellectual property and patent in stem cell research era.

Kiatpongsan S.

J Med Assoc Thai. 2006 Nov;89(11):1984-6. Review.

PMID:
17205886
[PubMed - indexed for MEDLINE]
8.
9.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
10.

Human induced pluripotent stem cells: a review of the US patent landscape.

Georgieva BP, Love JM.

Regen Med. 2010 Jul;5(4):581-91. doi: 10.2217/rme.10.43. Review.

PMID:
20632861
[PubMed - indexed for MEDLINE]
11.

Patent prosecution strategies for stem cell related applications.

Kumar R, Yeh JJ, Fernandez D, Hansen N.

J Biomol Screen. 2007 Sep;12(6):769-74.

PMID:
17848639
[PubMed - indexed for MEDLINE]
12.

The ethics of patenting human embryonic stem cells.

Chapman AR.

Kennedy Inst Ethics J. 2009 Sep;19(3):261-88.

PMID:
19886524
[PubMed - indexed for MEDLINE]
13.

Ethical questions to ponder in the European stem cell patent debate.

Curley D, Sharples A.

J Biolaw Bus. 2006;9(3):12-6.

PMID:
17152135
[PubMed - indexed for MEDLINE]
14.

Patently controversial: markets, morals, and the President's proposal for embryonic stem cell research.

Fins JJ, Schachter M.

Kennedy Inst Ethics J. 2002 Sep;12(3):265-78.

PMID:
12472079
[PubMed - indexed for MEDLINE]
15.

Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations.

Xu J, Kong X, Qiu L, Geng X, Hu Y, Wang Y.

Expert Opin Ther Pat. 2014 Jul;24(7):791-800. doi: 10.1517/13543776.2014.915943. Epub 2014 May 5.

PMID:
24798577
[PubMed - in process]
16.

ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.

[No authors listed]

Drugs R D. 2007;8(2):103-12. Review.

PMID:
17324008
[PubMed - indexed for MEDLINE]
17.

Patent protection for stem cell procedures under the law of the European Union.

Spranger TM.

Med Etika Bioet. 2003 Spring-Summer;10(1-2):4-8.

PMID:
16294439
[PubMed - indexed for MEDLINE]
19.

Scientists' perspectives on the ethical issues of stem cell research.

Longstaff H, Schuppli CA, Preto N, Lafrenière D, McDonald M.

Stem Cell Rev. 2009 Jun;5(2):89-95. doi: 10.1007/s12015-009-9068-y. Epub 2009 Apr 2.

PMID:
19521799
[PubMed - indexed for MEDLINE]
20.

Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

Huys I, Van Overwalle G, Matthijs G.

Eur J Hum Genet. 2011 Oct;19(10):1104-7. doi: 10.1038/ejhg.2011.76. Epub 2011 Jun 8.

PMID:
21654725
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk